CORIXA CORP
S-4, EX-23.5, 2000-11-07
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CORIXA CORP, S-4, EX-23.4, 2000-11-07
Next: CORIXA CORP, S-4, EX-23.6, 2000-11-07



<PAGE>   1

                                                                    EXHIBIT 23.5
                          [PACIFIC GROWTH LETTERHEAD]

November 3, 2000
Board of Directors
Corixa Corporation
1124 Columbia Street, Suite 200
Seattle, WA  98104-2040

Members of the Board:

       We hereby consent to the inclusion of our opinion letter to the Board of
Directors of Corixa Corporation as Appendix B to the joint proxy
statement/prospectus of Corixa Corporation constituting a part of the
Registration Statement on Form S-4 relating to the proposed merger and related
transactions involving Corixa and Coulter Pharmaceutical, Inc. and references
thereto in the joint proxy statement/prospectus under the captions "SUMMARY --
Opinion of Corixa's Financial Advisor", "THE MERGER -- Recommendation of
Corixa's Board; Corixa's Reasons for the Merger", "THE MERGER -- Opinion of
Corixa's Financial Advisor" and "THE MERGER -- History of the Transaction". In
giving such consent, we do not admit that we come within the category of persons
whose consent is required under, and we do not admit that we are "experts" for
purposes of, the Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder.



                                            PACIFIC GROWTH EQUITIES, INC.

                                            /s/ George J. Millstein
                                            ------------------------------------
                                            George J. Millstein




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission